triiodothyronine has been researched along with Spinal Diseases in 2 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Spinal Diseases: Diseases involving the SPINE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that treatment of postmenopausal osteoporosis with oestrogen/progestogen for 3 years results in net spinal bone gain and a positive effect on calcium balance slightly better than that of intermittent etidronate." | 2.67 | A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis. ( Charles, P; Hasling, C; Jensen, FT; Mosekilde, L, 1994) |
| "To elucidate the role of PTH in postmenopausal bone loss, we studied 33 postmenopausal patients who received total thyroidectomy due to thyroid carcinoma." | 1.29 | Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. ( Fujiyama, K; Ito, M; Kiriyama, T; Nagataki, S; Nakata, K; Yamashita, S; Yokoyama, N, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiyama, K | 1 |
| Kiriyama, T | 1 |
| Ito, M | 1 |
| Nakata, K | 1 |
| Yamashita, S | 1 |
| Yokoyama, N | 1 |
| Nagataki, S | 1 |
| Hasling, C | 1 |
| Charles, P | 1 |
| Jensen, FT | 1 |
| Mosekilde, L | 1 |
1 trial available for triiodothyronine and Spinal Diseases
| Article | Year |
|---|---|
A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.
Topics: Administration, Oral; Aged; Bone Density; Calcium; Drug Administration Schedule; Drug Therapy, Combi | 1994 |
1 other study available for triiodothyronine and Spinal Diseases
| Article | Year |
|---|---|
Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism.
Topics: Adult; Aged; Bone Density; Calcifediol; Calcitriol; Calcium; Female; Humans; Hypoparathyroidism; Inc | 1995 |